Life Sciences

FDA Reverses a Trump Administration Drug Review Transparency Policy

On April 30, the Food and Drug Administration (FDA) reversed a  Policy issued by the Department of Health and Human Services (HHS) near the end of the Trump Administration that was purportedly intended to increase drug review timeline transparency.  The Policy was announced in the Federal Register on January 15 and would have required FDA …

FDA Reverses a Trump Administration Drug Review Transparency Policy Read More »

Janet Woodcock is Named Acting FDA Commissioner, As Stephen Hahn Steps Down

In typical fashion, as the new administration took over, i.e., as President Biden was sworn in on Wednesday, Dr. Stephen M. Hahn resigned as FDA Commissioner.  His resignation was part of the routine departure of political appointees seen when a new President takes office. Dr. Janet Woodcock has become Acting Commissioner on an interim basis, …

Janet Woodcock is Named Acting FDA Commissioner, As Stephen Hahn Steps Down Read More »